Baillie Gifford & Co
BNR

Baillie Gifford & Co’s Burning Rock Biotech BNR Stock Holding History

Baillie Gifford & Co’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15,691
Closed -$152K – 292
2023
Q3 		$152K Sell
15,691
-327
-2% -$5.11K ﹤0.01% 281
2023
Q2 		$349K Hold
16,018
– – ﹤0.01% 281
2023
Q1 		$450K Hold
16,018
– – ﹤0.01% 278
2022
Q4 		$360K Hold
16,018
– – ﹤0.01% 288
2022
Q3 		$383K Sell
16,018
-17,771
-53% -$574K ﹤0.01% 286
2022
Q2 		$983K Sell
33,789
-857,336
-96% -$38.3M ﹤0.01% 275
2022
Q1 		$82.8M Buy
891,125
+1,075
+0.1% +$93.4K 0.06% 150
2021
Q4 		$84.8M Buy
890,050
+10,835
+1% +$1.48M 0.05% 152
2021
Q3 		$157M Buy
879,215
+32,973
+4% +$7.33M 0.08% 126
2021
Q2 		$249M Buy
846,242
+188,029
+29% +$55.6M 0.12% 117
2021
Q1 		$177M Buy
658,213
+500,457
+317% +$152M 0.1% 127
2020
Q4 		$36.4M Buy
157,756
+56,529
+56% +$15.2M 0.02% 178
2020
Q3 		$25.4M Buy
101,227
+29,367
+41% +$6.96M 0.02% 175
2020
Q2 		$19.4M Buy
+71,860
New +$19.7M 0.01% 170

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return

Baillie Gifford & Co's BNR Position: Q4 2023 in Review

Baillie Gifford & Co sold out of Burning Rock Biotech (BNR) in Q4 2023, closing a stake of 15,691 shares — an estimated $152K sold.

Baillie Gifford & Co first reported a position in BNR in Q2 2020 and held it in 14 quarters. The position peaked at $249M in Q2 2021. 19 funds tracked by Wall St. Rank hold BNR as of Q4 2023.

  • Baillie Gifford & Co reported no remaining Burning Rock Biotech position as of Q4 2023 after selling out during the quarter.
  • Baillie Gifford & Co sold 15,691 Burning Rock Biotech shares in Q4 2023, an estimated $152K.
  • Baillie Gifford & Co first reported a position in Burning Rock Biotech in Q2 2020 and held it in 14 quarters.
  • Baillie Gifford & Co's Burning Rock Biotech position peaked at $249M in Q2 2021.
  • 19 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2023.

Based on Baillie Gifford & Co's 13F filing for Q4 2023, filed 26 Jan 2024.